Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004 Mar 01; 22(5):872-80.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Aorta, Abdominal
Brachytherapy
Carcinoma, Adenosquamous
Carcinoma, Squamous Cell
Cisplatin
Combined Modality Therapy
Disease-Free Survival
Dose-Response Relationship, Radiation
Female
Fluorouracil
Follow-Up Studies
Humans
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Pelvis
Probability
Radiation Dosage
Reference Values
Risk Assessment
Survival Analysis
Treatment Outcome
Uterine Cervical Neoplasms

authors with profiles

CHARLES F LEVENBACK
PATRICIA J EIFEL